Staufen1 Represses the FOXA1-Regulated Transcriptome by Destabilizing FOXA1 mRNA in Colorectal Cancer Cells

Area of Science:

• Molecular Biology
• Cancer Research
• Gene Regulation

Background:

• Transcription factors like Forkhead box A1 (FOXA1) are crucial in development and disease.
• FOXA1 acts as an oncogene in prostate and breast cancers but shows tumor-suppressive roles in colorectal cancer (CRC).
• FOXA1 is downregulated in CRC, with higher expression correlating to better patient prognosis.

Purpose of the Study:

• To investigate the regulatory mechanisms controlling FOXA1 expression in colorectal cancer.
• To understand why FOXA1 is downregulated in CRC, despite its potential tumor-suppressive functions.

Main Methods:

• Genome-wide RNA stability assays to identify unstable mRNAs in CRC cells.
• Validation of mRNA instability in CRC cell lines and patient-derived organoids.
• RNA pulldown assays and mass spectrometry to identify RNA-binding proteins.
• Staufen1 (STAU1) knockdown experiments and subsequent RNA sequencing (RNA-seq).

Main Results:

• FOXA1 mRNA was identified as unstable in CRC cells, with the 3' untranslated region (3'UTR) conferring this instability.
• Staufen1 (STAU1) was identified as a key regulator of FOXA1 mRNA stability.
• STAU1 knockdown led to increased FOXA1 mRNA and protein levels, enhancing FOXA1 mRNA stability.
• Upregulation of FOXA1 target genes was observed upon STAU1 knockdown in CRC cells.

Conclusions:

• This study reveals a novel mechanism regulating FOXA1 expression in colorectal cancer via STAU1-mediated mRNA decay.
• The findings highlight STAU1 as a potential therapeutic target for increasing FOXA1's tumor-suppressive activity in CRC.
• Provides critical insights into the complex gene regulation networks operating in cancer.